- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01094431
Etiology of Uncomplicated Fever in Children <5 in Rural Zanzibar (RDTNEG)
December 2, 2014 updated by: Anders Björkman, Karolinska University Hospital
Infectious Disease Etiologies of Uncomplicated Febrile Illness in Children <5 Years of Age in Rural Zanzibar
The purpose of this study is to study the most common etiologies of uncomplicated fever diseases among children under five years of age in rural Zanzibar.
Study Overview
Status
Completed
Conditions
Detailed Description
During the last 6 years Zanzibar has undergone a dramatic change in malaria epidemiology and burden of disease, with a marked decline of Plasmodium falciparum malaria among febrile children from approximately 30% to 1% or below and a reduction of crude child mortality of 50%.
Millions of children in Africa die of neonatal disorders, acute respiratory tract infections (ARI), diarrhea, malaria, measles, HIV and malnutrition.
A majority of these illnesses are also a common cause of febrile illness in out-patient departments.
However, most of the few fever studies made in Africa are hospital based Very few studies on etiology of childhood febrile disease have been conducted on first level health facilities in the least developed countries in Africa.
This study will therefore focus on children between 2 months to 5 years of age that have been diagnosed with a negative rapid diagnostic test (RDT) for malaria and their causes of fever at the first referral level in out-patient clinics in Zanzibar.
Study Type
Observational
Enrollment (Actual)
690
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zanzibar
-
Kivunge, Zanzibar, Tanzania
- Facility: Primary health care center (PHCC), Kivunge, North A district, Zanzibar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 months to 4 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Kivunge Primary Health Care Center (PHCC) in North A District in Zanzibar
Description
Inclusion Criteria:
- Patients between 2-59 months of age with confirmed fever, with a measured axillary temperature of ≥37.5˚C, or history of fever within the preceding 24 hours.
- Presenting at the health facility from 8.00 to 16.00 Monday to Friday.
- Informed consent.
- Able and willing to complete stipulated follow-up.
Exclusion Criteria:
- Decision by the clinician to refer the patient to another health facility than the PHCC where the study is conducted.
- Symptoms/ signs of severe disease that requires immediate referral from the PHCC as defined by the clinicians. These symptoms/signs of severe disease are according to the IMCI guidelines.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
relative frequency of febrile diseases etiology
Time Frame: Five months
|
Five months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Anders Björkman, Professor, Karolinska University Hopsital
- Principal Investigator: Magnus Lindh, Professor, Sahlgrenska University Hospital, Gothenburg, Sweden
- Principal Investigator: Mwinyi Msellem, MSc, Zanzibar Malaria Control Programme
- Principal Investigator: Abdullah S. Ali, Manager, Zanzibar Malaria Control Programme
- Principal Investigator: Birger Trollfors, Professor, Sahlgrenska University Hospital, Gothenburg, Sweden
- Principal Investigator: Andreas Mårtensson, MD, PhD,, Karolinska University Hospital
- Principal Investigator: Kristina Elfving, M.D., Sahlgrenska University Hospital, Gothenburg, Sweden
- Principal Investigator: Delér Shakely, M.D., Karolinska University Hopsital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
July 1, 2011
Study Registration Dates
First Submitted
March 26, 2010
First Submitted That Met QC Criteria
March 26, 2010
First Posted (Estimate)
March 29, 2010
Study Record Updates
Last Update Posted (Estimate)
December 3, 2014
Last Update Submitted That Met QC Criteria
December 2, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fever 2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infectious Disease
-
Centre de Recherche Médicale de LambarénéNot yet recruitingTropical Infectious Disease
-
Shaare Zedek Medical CenterTerminatedInfectious Disease TransmissionIsrael
-
The Third Xiangya Hospital of Central South UniversitySANSURE BIOTECH INC.UnknownInfectious Disease ScreeningChina
-
The Hong Kong Polytechnic UniversityCompletedInfectious Disease TransmissionHong Kong
-
CerbaXpertRecruiting
-
Carecubes, Inc.University of NebraskaCompletedInfectious DiseasesUnited States
-
King Saud Medical CityUnknown
-
BayerCompletedInfectious DiseasesItaly
-
Universidad de GuanajuatoAntisepsia CentralCompleted
-
LG Life SciencesCompleted